About DeepenDrugs
DeepenDrugs is a company based in Ahmedabad (India) founded in 1982. It operates as a B2B. The company has 1 employees as of March 31, 2023. DeepenDrugs offers products and services including ACECLOFENAC, BROMHEXINE, CYPROHEPTEDIN, DIACEREIN, and ETORICOXIB. DeepenDrugs operates in a competitive market with competitors including Laurus Labs, Symbiotec, Provepharm Life Solutions, Beijing Biostar Technologies and Sterling Pharma Solutions, among others.
- Headquarter Ahmedabad, India
- Employees 1 as on 31 Mar, 2023
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
- Legal Name Deependrugs Private Limited
- Date of Incorporation 23 May, 2020
- Jurisdiction Ahmedabad, Gujarat, India
-
Annual Revenue
$3.35 M (USD)-8.89as on Mar 31, 2023
-
Net Profit
$1.79 K (USD)-76.26as on Mar 31, 2023
-
EBITDA
$59.64 K (USD)-18.36as on Mar 31, 2023
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
1
as on Mar 31, 2023
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of DeepenDrugs
DeepenDrugs offers a comprehensive portfolio of products and services, including ACECLOFENAC, BROMHEXINE, CYPROHEPTEDIN, DIACEREIN, and ETORICOXIB.
Active ingredient used for anti-inflammatory treatments.
Mucolytic agent for respiratory condition management.
Medication for appetite stimulation and allergy relief.
Compound for osteoarthritis and joint health support.
Anti-inflammatory drug for pain and inflammation control.
Antipsychotic medication for mental health disorders.
Acid reducer for gastrointestinal condition treatment.
Antibiotic for parasitic and bacterial infections.
Funding Insights of DeepenDrugs
Detailed funding history for DeepenDrugs
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by DeepenDrugs
Investment portfolio details for DeepenDrugs
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - DeepenDrugs
Detailed financials for DeepenDrugs
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Deependrugs Comparisons
Peer comparison for DeepenDrugs
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of DeepenDrugs
DeepenDrugs operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Laurus Labs, Symbiotec, Provepharm Life Solutions, Beijing Biostar Technologies and Sterling Pharma Solutions, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Pharmaceutical and biotechnology company
|
|
| Locked | Locked | Locked |
Non-sterile steroid hormone-based APIs and intermediates are manufactured.
|
|
| Locked | Locked | Locked |
APIs and drug products are developed and valorized in pharmaceuticals.
|
|
| Locked | Locked | Locked |
APIs, intermediates, and biochemical reagents are developed and manufactured.
|
|
| Locked | Locked | Locked |
Contract development, manufacturing, and analytical services for APIs are offered.
|
|
| Locked | Locked | Locked |
APIs are developed and manufactured for therapeutic areas.
|
Detailed competitors of DeepenDrugs
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Deependrugs
Complete news archive for DeepenDrugs
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about DeepenDrugs
DeepenDrugs was founded in 1982.
DeepenDrugs is headquartered in Ahmedabad, India. It is registered at Ahmedabad, Gujarat, India.
As of Mar 31, 2023, the latest employee count at DeepenDrugs is 1.
Annual revenue of DeepenDrugs is $3.35M as on Mar 31, 2023.
DeepenDrugs Pvt. Ltd., established in 1982 in Ahmedabad, India, specializes in sourcing and supplying active pharmaceutical ingredients, excipients, chemicals, solvents, and nutraceuticals. The company operates as a wholesale trader, focusing on the pharmaceutical industry with a team-based approach to meet industry needs. It serves clients in the healthcare sector through reliable product distribution and expertise.
DeepenDrugs's top competitors include Laurus Labs, Symbiotec and Beijing Biostar Technologies.
DeepenDrugs offers ACECLOFENAC, BROMHEXINE, CYPROHEPTEDIN, DIACEREIN, and 4 more products and services.